Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV

Since the beginning of the COVID-19 pandemic, large in silico screening studies and numerous in vitro studies have assessed the antiviral activity of various drugs on SARS-CoV-2. In the context of health emergency, drug repurposing represents the most relevant strategy because of the reduced time fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aherfi, Sarah, Pradines, Bruno, Devaux, Christian, Honore, Stéphane, Colson, Philippe, Scola, Bernard La, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579950/
https://www.ncbi.nlm.nih.gov/pubmed/34755538
http://dx.doi.org/10.2217/fmb-2021-0019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579950/
https://www.ncbi.nlm.nih.gov/pubmed/34755538
http://dx.doi.org/10.2217/fmb-2021-0019

Ejemplares similares